{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T14:40:23Z","timestamp":1760712023135,"version":"build-2065373602"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Science and Education Cultivation Fund of the National Cancer and Regional Medical center of Shanxi Provincial Cancer hospital","award":["SD2023005","SD2023005"],"award-info":[{"award-number":["SD2023005","SD2023005"]}]},{"name":"Shanxi Provincial Key Discipline Special Fund","award":["No: 2025051","No: 2025051"],"award-info":[{"award-number":["No: 2025051","No: 2025051"]}]},{"name":"Central Government Fund for Guiding Local Science and Technology Development Project","award":["No: YDZJSX 2022B014)","No: YDZJSX 2022B014)"],"award-info":[{"award-number":["No: YDZJSX 2022B014)","No: YDZJSX 2022B014)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-04043-2","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T13:58:43Z","timestamp":1760709523000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exploring the prognosis of rictor(+) in high-risk population: lasso regression for enhancing overall survival in primary gastric adenocarcinoma"],"prefix":"10.1186","volume":"23","author":[{"given":"Wenhua","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinfeng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruifang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"issue":"3","key":"4043_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"4043_CR2","doi-asserted-by":"publisher","first-page":"17036","DOI":"10.1038\/nrdp.2017.36","volume":"3","author":"JA Ajani","year":"2017","unstructured":"Ajani JA, Lee J, Sano T, et al. Gastric adenocarcinoma. Nat Rev Dis Primers. 2017;3:17036.","journal-title":"Nat Rev Dis Primers"},{"issue":"7","key":"4043_CR3","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1053\/j.gastro.2018.01.068","volume":"154","author":"MJ Bourke","year":"2018","unstructured":"Bourke MJ, Neuhaus H, Bergman JJ. Endoscopic submucosal dissection: indications and application in Western endoscopy practice. Gastroenterology. 2018;154(7):1887\u2013e19005.","journal-title":"Gastroenterology"},{"key":"4043_CR4","doi-asserted-by":"publisher","first-page":"101889","DOI":"10.1016\/j.ctrv.2019.101889","volume":"79","author":"M Salati","year":"2019","unstructured":"Salati M, Orsi G, Smyth E, et al. Gastric cancer: translating novel concepts into clinical practice. Cancer Treat Rev. 2019;79:101889.","journal-title":"Cancer Treat Rev"},{"key":"4043_CR5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.gtc.2013.01.002","volume":"42","author":"P Correa","year":"2013","unstructured":"Correa P. Gastric cancer: overview. Gastroenterol Clin North Am. 2013;42:211\u20137.","journal-title":"Gastroenterol Clin North Am"},{"key":"4043_CR6","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0140-6736(10)61121-X","volume":"376","author":"YJ Bang","year":"2010","unstructured":"Bang YJ, Van Cutsem E, Feyereislova A, et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomized controlled trial. Lancet. 2010;376:687\u201397.","journal-title":"Lancet"},{"key":"4043_CR7","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(13)61719-5","volume":"383","author":"CS Fuchs","year":"2014","unstructured":"Fuchs CS, Tomasek J, Yong CJ, et al. Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomized, multicentre, placebo-controlled, phase 3 trial. Lancet. 2014;383:31\u20139.","journal-title":"Lancet"},{"issue":"2","key":"4043_CR8","doi-asserted-by":"publisher","first-page":"96","DOI":"10.5603\/FHC.a2020.0015","volume":"58","author":"F Wang","year":"2020","unstructured":"Wang F, Lou X, Zou Y, et al. Overexpression of rictor protein and rictor-H. Pylori interaction has an impact on tumor progression and prognosis in patients with gastric cancer. Folia Histochem Cytobiol. 2020;58(2):96\u2013107.","journal-title":"Folia Histochem Cytobiol"},{"issue":"2","key":"4043_CR9","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.bbrc.2015.07.001","volume":"464","author":"Y Bian","year":"2015","unstructured":"Bian Y, Wang Z, Xu J, et al. Elevated rictor expression is associated with tumor progression and poor prognosis in patients with gastric cancer. Biochem Biophys Res Commun. 2015;464(2):534\u201340.","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"4043_CR10","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.urolonc.2009.11.009","volume":"30","author":"MJ Wu","year":"2012","unstructured":"Wu MJ, Chang CH, Chiu YT, et al. Rictor-dependent AKT activation and inhibition of urothelial carcinoma by rapamycin. Urol Oncol. 2012;30(1):69\u201377.","journal-title":"Urol Oncol"},{"issue":"4","key":"4043_CR11","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1128\/MCB.00601-09","volume":"30","author":"LA Julien","year":"2010","unstructured":"Julien LA, Carriere A, Moreau J, et al. mTORC1-activated S6K1 phosphorylates rictor on threonine 1135 and regulates mTORC2 signaling. Mol Cell Biol. 2010;30(4):908\u201321.","journal-title":"Mol Cell Biol"},{"issue":"3","key":"4043_CR12","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s12032-017-0894-5","volume":"34","author":"WJ Jiang","year":"2017","unstructured":"Jiang WJ, Feng RX, Liu JT, et al. Rictor expression in esophageal squamous cell carcinoma and its clinical significance. Med Oncol. 2017;34(3):32.","journal-title":"Med Oncol"},{"issue":"5","key":"4043_CR13","first-page":"2068","volume":"7","author":"SY Wen","year":"2014","unstructured":"Wen SY, Li CH, Zhang YL, et al. Rictor is an independent prognostic factor for endometrial carcinoma. Int J Clin Exp Pathol. 2014;7(5):2068\u201378.","journal-title":"Int J Clin Exp Pathol"},{"key":"4043_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.641453","volume":"11","author":"RZ Cao","year":"2021","unstructured":"Cao RZ, Min L, Liu S, et al. Rictor activates Cav 1 through the Akt signaling pathway to inhibit the apoptosis of gastric cancer cells. Front Oncol. 2021;11:641453.","journal-title":"Front Oncol"},{"issue":"3","key":"4043_CR15","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/annonc\/mdw669","volume":"28","author":"ST Kim","year":"2017","unstructured":"Kim ST, Kim SY, Klempner SJ, et al. Rapamycin-insensitive companion of mTOR (RICTOR) amplification defines a subset of advanced gastric cancer and is sensitive to AZD2014-mediated mTORC1\/2 inhibition. Ann Oncol. 2017;28(3):547\u201354.","journal-title":"Ann Oncol"},{"issue":"4","key":"4043_CR16","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.bbamcr.2010.01.009","volume":"1803","author":"SA Lang","year":"2010","unstructured":"Lang SA, Hackl C, Moser C, et al. Implication of RICTOR in the mTOR inhibitor-mediated induction of insulin-like growth factor-I receptor (IGF-IR) and human epidermal growth factor receptor-2 (Her2) expression in gastrointestinal cancer cells. Biochim Biophys Acta. 2010;1803(4):435\u201342.","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"4043_CR17","doi-asserted-by":"publisher","first-page":"96","DOI":"10.5603\/FHC.a2020.0015","volume":"58","author":"F Wang","year":"2020","unstructured":"Wang F, Lou X, Zou Y, et al. Overexpression of rictor protein and rictor-H. pylori interaction has impact on tumor progression and prognosis in patients with gastric cancer. Folia Histochem Cytobiol. 2020;58(2):96\u2013107.","journal-title":"Folia Histochem Cytobiol"},{"issue":"5","key":"4043_CR18","doi-asserted-by":"publisher","first-page":"e388","DOI":"10.3747\/co.20.1417","volume":"20","author":"F Wang","year":"2013","unstructured":"Wang F, Sun GP, Zou YF, et al. Helicobacter pylori infection predicts favorable outcomes in patients with gastric cancer. Curr Oncol. 2013;20(5):e388\u201395.","journal-title":"Curr Oncol"},{"key":"4043_CR19","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jdermsci.2017.02.281","volume":"86","author":"T Yanagi","year":"2017","unstructured":"Yanagi T, Hata H, Mizuno E, et al. PCTAIRE1\/CDK16\/PCTK1 is overexpressed in cutaneous squamous cell carcinoma and regulates p27 stability and cell cycle. J Dermatol Sci. 2017;86:149\u201357.","journal-title":"J Dermatol Sci"},{"key":"4043_CR20","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nrc2347","volume":"8","author":"IM Chu","year":"2008","unstructured":"Chu IM, Hengst L, Slingerland JM. The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy. Nat Rev Cancer. 2008;8:253\u201367.","journal-title":"Nat Rev Cancer"},{"key":"4043_CR21","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.7150\/jca.14778","volume":"7","author":"YQ Sun","year":"2016","unstructured":"Sun YQ, Xie JW, Chen PC, et al. Low expression of CDK5 and p27 is associated with poor prognosis in patients with gastric cancer. J Cancer. 2016;7:1049\u201356.","journal-title":"J Cancer"},{"issue":"9","key":"4043_CR22","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.7150\/jca.14778","volume":"7","author":"YQ Sun","year":"2016","unstructured":"Sun YQ, Xie JW, Chen PC, et al. Low expression of CDK5 and p27 are associated with poor prognosis in patients with gastric cancer. J Cancer. 2016;7(9):1049\u201356. https:\/\/doi.org\/10.7150\/jca.14778. PMID: 27326247; PMCID: PMC4911871.","journal-title":"J Cancer"},{"issue":"1","key":"4043_CR23","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3906\/sag-1311-107","volume":"45","author":"M \u00c7alik","year":"2015","unstructured":"\u00c7alik M, Demirci E, Altun E, et al. Clinicopathological importance of Ki-67, p27, and p53 expression in gastric cancer. Turk J Med Sci. 2015;45(1):118\u201328.","journal-title":"Turk J Med Sci"},{"issue":"4","key":"4043_CR24","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1007\/s12094-020-02479-4","volume":"23","author":"S Kumari","year":"2021","unstructured":"Kumari S, Kumar P, Kumar M, et al. Expression of p27 and p16 and their clinical significance in gastric cancer. Clin Transl Oncol. 2021;23(4):856\u201365.","journal-title":"Clin Transl Oncol"},{"issue":"1","key":"4043_CR25","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/ncb2641","volume":"15","author":"PA Muller","year":"2013","unstructured":"Muller PA, Vousden KH. p53 mutations in cancer. Nat Cell Biol. 2013;15(1):2\u20138.","journal-title":"Nat Cell Biol"},{"issue":"2","key":"4043_CR26","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nrc3430","volume":"13","author":"M Wade","year":"2013","unstructured":"Wade M, Li YC, Wahl GM. MDM2, MDMX, and p53 in oncogenesis and cancer therapy. Nat Rev Cancer. 2013;13(2):83\u201396.","journal-title":"Nat Rev Cancer"},{"key":"4043_CR27","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7779770","volume":"2022","author":"MA Abu-Lubad","year":"2022","unstructured":"Abu-Lubad MA, Helaly GF, Haddadin WJ, et al. Loss of p53 expression in gastric epithelial cells of Helicobacter pylori-infected Jordanian patients. Int J Microbiol. 2022;2022:7779770.","journal-title":"Int J Microbiol"},{"issue":"8","key":"4043_CR28","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1002\/jso.23599","volume":"109","author":"X Liu","year":"2014","unstructured":"Liu X, Yu H, Cai H, Wang Y. Expression of CD24, p21, p53, and c-myc in alpha-fetoprotein-producing gastric cancer: correlation with clinicopathologic characteristics and survival. J Surg Oncol. 2014;109(8):859\u201364.","journal-title":"J Surg Oncol"},{"issue":"1","key":"4043_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-019-0661-x","volume":"11","author":"YJ Shin","year":"2019","unstructured":"Shin YJ, Kim Y, Wen X, et al. Prognostic implications and interaction of L1 methylation and p53 expression statuses in advanced gastric cancer. Clin Epigenetics. 2019;11(1):77.","journal-title":"Clin Epigenetics"},{"issue":"2","key":"4043_CR30","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/bioinformatics\/btab659","volume":"38","author":"F Motamedi","year":"2022","unstructured":"Motamedi F, P\u00e9rez-S\u00e1nchez H, Mehridehnavi A, et al. Accelerating big data analysis through LASSO-random forest algorithm in QSAR studies. Bioinformatics. 2022;38(2):469\u201375.","journal-title":"Bioinformatics"},{"issue":"5","key":"4043_CR31","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1080\/00273171.2015.1036965","volume":"50","author":"DM McNeish","year":"2015","unstructured":"McNeish DM. Using lasso for predictor selection and to assuage overfitting: a method long overlooked in behavioral sciences. Multivar Behav Res. 2015;50(5):471\u201384.","journal-title":"Multivar Behav Res"},{"key":"4043_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2022.916483","volume":"9","author":"Y Li","year":"2022","unstructured":"Li Y, Zhang X. Prognostic nomograms for gastric carcinoma after surgery to assist decision-making for postoperative treatment with chemotherapy cycles < 9 or chemotherapy cycles \u2265 9. Front Surg. 2022;9:916483.","journal-title":"Front Surg"},{"issue":"1","key":"4043_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12957-023-03097-4","volume":"21","author":"Y Li","year":"2023","unstructured":"Li Y, Bai M, Gao Y. Prognostic nomograms for gastric carcinoma after D2\u2009+\u2009total gastrectomy to assist decision-making for postoperative treatment: based on Lasso regression. World J Surg Oncol. 2023;21(1):207.","journal-title":"World J Surg Oncol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04043-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-04043-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-04043-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T13:58:44Z","timestamp":1760709524000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-04043-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4043"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-04043-2","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"9 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Following rigorous consultation with the Shanxi Cancer Hospital Ethics Committee, ethical approval was granted under reference number 2022JC23. All research protocols were meticulously aligned with applicable guidelines and institutional policies. Additionally, the enrolment of human participants was executed by the ethical benchmarks established by our institutional review board. Informed consent was obtained from each volunteer, affirming their willing participation in the study. For this publication, explicit written informed consent, including any associated imagery, has been obtained from the patient. The journal\u2019s Editor-in-Chief.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"380"}}